Company & Sponsor Intelligence

Biohaven Therapeutics Ltd.

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials3

Recruiting0

Completed1

Countries1

Therapeutic footprint

bipolar_disorderepilepsy

Indexed studies

NCT07262268A Phase 1b Study of BHV-7000 in Participants With Inherited Erythromelalgia
epilepsy · United StatesPHASE1

NCT06419582BHV-7000 Acute Treatment of Bipolar Mania
bipolar_disorder · United StatesPHASE2, PHASE3

NCT06443463Long-term Safety and Tolerability of BHV-7000
epilepsy · United StatesPHASE2

Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →